Status | Study |
Completed |
Study Name: Zinc for the Treatment of Herpes Simplex Labialis (HSL) Condition: Herpes Simplex Labialis Date: 2008-12-15 Interventions: Drug: Zicam (Ionic zinc) 33mmo |
Completed |
Study Name: Safety of a Herpes Simplex Candidate Vaccine (gD2t) With MPL and Its Efficacy to Prevent Genital Herpes Disease Condition: Herpes Simplex Date: 2008-06-17 Interventions: Biological: Herpes simplex candidate vaccine- adjuvanted GSK208141 |
Completed |
Study Name: Safety Evaluation of Herpes Simplex Candidate Vaccine (gD2t) With Adjuvant in HSV Seropositive / Seronegative Subjects Condition: Prophylaxis for Herpes Simplex Date: 2008-06-16 Interventions: Biological: Herpes simplex candidate vaccine- adjuvanted GSK 208141 |
Completed |
Study Name: Evaluation of Safety of Candidate gD Vaccine, With or Without MPL in Healthy Herpes Simplex Virus-Positive Adults Condition: Prophylaxis Herpes Simplex Date: 2008-06-13 Interventions: Biological: Herpes simplex candidate (gD) vaccine GSK208141 Intramuscular injection, 2 doses, 2 differen |
Completed |
Study Name: Humoral and Cellular Immune Response of Herpes Simplex (gD) Candidate Vaccines From 2 Different Cell Lines Condition: Prophylaxis Herpes Simplex Date: 2008-06-13 Interventions: Biological: Adjuvanted herpes simplex (gD) candidate vaccine GSK 208141 |
Completed |
Study Name: Evaluation of Immunogenicity, Reactogenicity and Safety of Herpes Simplex (gD) Candidate Vaccine With/Without Adjuvant Condition: Prophylaxis Herpes Simplex Date: 2008-06-12 Interventions: Biological: Herpes simplex candidate vaccine GSK208141 - non-MPL-containing |
Completed |
Study Name: Pharmacokinetics, Acceptability and Safety of Famciclovir in Infants (1 Month to Less Than 12 Months) With Herpes Simplex Infection Condition: Herpes Simplex Date: 2007-03-15 Interventions: Drug: famciclovir Administered orally as a single individualized dose between 25-200 mg based on body we |
Completed |
Study Name: The Efficacy of Two Potential Diagnostic Assays for Herpes Simplex Keratitis (HSK) Condition: Herpes Simplex Keratitis Date: 2006-07-26 |
Completed |
Study Name: Safety Study of Herpes Simplex Vaccine in HSV Seronegative and Seropositive Females Between 10 and 17 Years Old Condition: Herpes Simplex Date: 2005-09-21 Interventions: Biological: GSK208141 3 IM dos |
Completed |
Study Name: Study to Compare Safety and Immunogenicity of Commercial Scale Consistency Lots of Herpes Simplex Vaccine Condition: Herpes Simplex Date: 2005-09-21 Interventions: Biological: GSK208141 vaccine 3 IM doses Other Name: |